This is because of too little safety data and case reports that cant exclude harm
This dual mechanism enhances insulin secretion, suppresses glucagon release, slows gastric emptying, and reduces appetite
A well-designed network meta-analysis (NMA) of GLP-1 receptor agonists and SGLT2 inhibitors, which allows for direct comparisons among different medications, could enhance the ability to make multiple treatment efficacy comparisons and assess the potential superiority of specific interventions at various dosages [12]
However, both medications can influence gastrointestinal function and appetite signals, creating indirect effects that warrant monitoring
Heres how MDL cases generally work: Formation of MDL Cases The litigation process begins when parties petition the Judicial Panel on Multidistrict Litigation (JPML), a special body of seven federal judges, to consolidate related federal court lawsuits into a single district